MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Benefits of Parkinson’s Team Training Are Maintained Long-Term

    K. Lyons, E. Pollard, D. Beran, C. Hunter(†), H. Cianci, E. Book (Kansas City, USA)

    Objective: To determine if the improvements in confidence to provide and coordinate patient care and understanding of individual and other team member roles among interprofessional…
  • 2024 International Congress

    Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review

    J. Saade, T. Mestre, G. Stebbins, A. van Wyk (Ottawa, Canada)

    Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…
  • 2024 International Congress

    Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

    A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)

    Objective: To study mechanisms of cellular inflammation and neurodegeneration of EVs derived from patients with PD at different disease stages in cell-based disease models. Background:…
  • 2024 International Congress

    CSF Neurogranin Levels Are Decreased in Parkinson Disease

    H. Hwang, R. Miller, T. Cash, A. Eid, E. Herries, R. White Iii, B. Maiti, S. Schindler, J. Jackson, J. Perlmutter, M. Campbell, P. Kotzbauer (SAINT LOUIS, USA)

    Objective: To investigate CSF neurogranin differences in participants with Parkinson disease (PD) and controls and to examine its association with motor and cognitive symptoms. Background:…
  • 2024 International Congress

    A Cross-Sectional Study of Sleep Disturbances in Parkinson’s Disease Patients at a Tertiary Neurological Center in Nepal

    AYU. Chandra, AVI. Chandra (Tianjin, China)

    Objective: The objective of this cross-sectional study is to assess the prevalence and types of sleep disturbances among Parkinson's disease patients receiving care at a…
  • 2024 International Congress

    Parkinsonism in setting of hypoparathyroidism

    R. Fekete (Hawthorne, USA)

    Objective: There may be overlap between symptoms of hypoparathyroidism such as tremor and bradykinesia and Parkinsonism. Recognizing this possibility allows for appropriate clinical management. Background:…
  • 2024 International Congress

    Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

    MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)

    Objective: To verify whether connectivity changes in the dorsolateral prefrontal cortex (DLPC) and the precuneus (PCun) can predict cognitive phenotypes in de novo Parkinson’s disease…
  • 2024 International Congress

    Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

    SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

    Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…
  • 2024 International Congress

    Evidence of basal ganglia involvement in mask-induced inhibition

    P. Daye, A. Sangaré, B. Gaymard, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)

    Objective: This study evaluates if basal ganglia inhibitory projections to the superior colliculus are involved in the saccadic mask inhibition phenomenon. Background: Saccadic mask inhibition is…
  • 2024 International Congress

    Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

    C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)

    Objective: Assess the comparative effectiveness of behavioral or solifenacin drug therapy over 12 weeks for overactive bladder (OAB) symptoms according to the International Consultation on…
  • « Previous Page
  • 1
  • …
  • 266
  • 267
  • 268
  • 269
  • 270
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley